Variant report
Variant | nsv974332 |
---|---|
Chromosome Location | chr14:43524463-43546649 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs76472295 | chr14:43528606-43528607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs559063855 | chr14:43528626-43528627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs577202172 | chr14:43528629-43528630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs1954378 | chr14:43528638-43528639 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs1954379 | chr14:43528641-43528642 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs147322076 | chr14:43528687-43528688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs140745183 | chr14:43528696-43528697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs73334441 | chr14:43528724-43528725 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs528732364 | chr14:43528725-43528726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76859451 | chr14:43528737-43528738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571794242 | chr14:43528769-43528770 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539539223 | chr14:43531034-43531035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs75316252 | chr14:43531035-43531036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs186295533 | chr14:43531041-43531042 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs72668958 | chr14:43531077-43531078 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs368017293 | chr14:43531129-43531130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs556388747 | chr14:43531155-43531156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs143274068 | chr14:43531163-43531164 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs562667152 | chr14:43531171-43531172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs144680994 | chr14:43531207-43531208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs73334459 | chr14:43531217-43531218 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs113663795 | chr14:43531250-43531251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564194796 | chr14:43531256-43531257 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73334460 | chr14:43531301-43531302 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs2488855 | chr14:43531322-43531323 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs191222080 | chr14:43531325-43531326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs72668960 | chr14:43531335-43531336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527703282 | chr14:43531339-43531340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs565932959 | chr14:43531342-43531343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs539675064 | chr14:43531352-43531353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs183012230 | chr14:43531356-43531357 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs73334464 | chr14:43531360-43531361 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs550593658 | chr14:43531377-43531378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs73334466 | chr14:43531385-43531386 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs547755337 | chr14:43531396-43531397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs2488856 | chr14:43531402-43531403 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | disease |
37 | rs111916526 | chr14:43531411-43531412 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs74047539 | chr14:43531432-43531433 | Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs73334468 | chr14:43531470-43531471 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150634948 | chr14:43531479-43531480 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546052525 | chr14:43531495-43531496 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139325835 | chr14:43531496-43531497 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs567629966 | chr14:43531497-43531498 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs377214260 | chr14:43531512-43531513 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs144091966 | chr14:43531513-43531514 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs538799381 | chr14:43531545-43531546 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528932344 | chr14:43531554-43531555 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs113756229 | chr14:43531559-43531560 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs192870826 | chr14:43531565-43531566 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533316766 | chr14:43531575-43531576 | Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal cancer | 21851588 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 17899364 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Chronic myeloid leukemia | 20724749 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Wilms tumour | 21544195 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 21858162 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Breast cancer | 21364760 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 20967226 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Type 2 diabetes | 21526130 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr14:43528600-43528800 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
2 | chr14:43531000-43531400 | Enhancers | A549 | lung |
3 | chr14:43531400-43531600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
4 | chr14:43531400-43532000 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
5 | chr14:43531400-43532000 | Active TSS | HUES6 Cell Line | embryonic stem cell |
6 | chr14:43531400-43532000 | Active TSS | A549 | lung |
7 | chr14:43531600-43532000 | Active TSS | ES-WA7 Cell Line | embryonic stem cell |
8 | chr14:43531600-43532000 | Active TSS | H9 Cell Line | embryonic stem cell |
9 | chr14:43531600-43532000 | Active TSS | HUES48 Cell Line | embryonic stem cell |
10 | chr14:43531600-43532000 | Active TSS | HUES64 Cell Line | embryonic stem cell |
11 | chr14:43531600-43532000 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
12 | chr14:43531600-43532000 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
13 | chr14:43531600-43532000 | Active TSS | iPS DF 19.11 Cell Line | embryonic stem cell |